LENZ and Lotus Pharmaceutical collaborate to commercialise presbyopia treatment
US-based LENZ Therapeutics has announced an exclusive licensing and commercialisation agreement with Lotus Pharmaceutical of Taiwan for the commercialisation of …
US-based LENZ Therapeutics has announced an exclusive licensing and commercialisation agreement with Lotus Pharmaceutical of Taiwan for the commercialisation of …
The use of Valneva’s chikungunya vaccine, known under the brand name Ixchiq, has been paused in elderly individuals after reports …
Eli Lilly and Purdue University, US, have announced the widening of their existing partnership with a planned investment of up …
The American Academy of Neurology (AAN) Annual Meeting 2025 took place in San Diego, California on April 5-9, 2025. This prestigious …
To assess the impact of pharmaceutical policy and market dynamics on market access, GlobalData has conducted a comparative analysis of …
US-based LENZ Therapeutics has announced an exclusive licensing and commercialisation agreement with Lotus Pharmaceutical of Taiwan for the commercialisation of …
The use of Valneva’s chikungunya vaccine, known under the brand name Ixchiq, has been paused in elderly individuals after reports …
Eli Lilly and Purdue University, US, have announced the widening of their existing partnership with a planned investment of up …
The American Academy of Neurology (AAN) Annual Meeting 2025 took place in San Diego, California on April 5-9, 2025. This prestigious …
To assess the impact of pharmaceutical policy and market dynamics on market access, GlobalData has conducted a comparative analysis of …
HLS Therapeutics has signed an agreement with Esperion Therapeutics for in-licensing and commercialising the oral cardiovascular medicines, Nexletol (bempedoic acid) …
Bavarian Nordic is successfully navigating a sentiment-changing vaccine landscape, posting Q1 revenues significantly up from the same period in 2024. The …
Swiss biotechnology company NewBiologix has given a non-exclusive technology licence to Recipharm Advanced Bio to provide biotech and pharma companies …
The US Food and Drug Administration (FDA) has set an "aggressive" timeline to implement generative artificial intelligence (genAI) across the …
Haya Therapeutics has procured $65m in Series A funding to expedite the clinical development of HTX-001 for treating heart failure. The …